Yahoo Web Search

Sign In

  1. Ad

    related to: jnj dividend history
  2. JNJ.com

    Johnson & Johnson - J&J investor information

    Get information about J&J's stock, annual shareholder meeting, SEC filings and more. See how J&J is delivering long-term value for our stakeholders.

Search results

  1. 147.78
    Add to watchlist
    +2.13 (+1.46%)
    At close:4:00 PM EDTThu. Jun 20, 2024
    147.78 0.00 (0.00%)
    After hrs:5:37 PM EDTThu. Jun 20, 2024
    Nasdaq Real Time Price (USD) · Market closed
    Full chart
    • Open
      145.27
      High
      148.08
      Low
      145.02
    • Mkt Cap
      355.66B
      P/E (TTM)
      21.96
      Div & Yield
      4.96 & 3.41%
    • Prev. Close
      145.65
      52 Wk. Low
      143.13
      52 Wk. High
      175.97

    More about JNJ

    What analysts are saying
    Morningstar Bullish Published May 24 · Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now... Read more
    Top stories

    Related stocks

    More on Yahoo Finance

  2. www.nasdaq.com › articles › ex-dividend-reminderEx-Dividend Reminder: Restaurant Brands International ...

    5 hours ago · Restaurant Brands International Inc will pay its quarterly dividend of $0.58 on 7/5/24, Johnson Controls International plc will pay its quarterly dividend of $0.37 on 7/19/24, and Philip Morris ...

  3. www.nasdaq.com › articles › upcoming-dividend-run-jpmUpcoming Dividend Run For JPM? | Nasdaq

    5 hours ago · In about two weeks from now, JPMorgan Chase & Co (NYSE: JPM) will go ex-dividend for its latest dividend of 1.15/share. Will Dividend Run history repeat itself? Upcoming Dividend: 1.15/share. Ex ...

  4. www.streetinsider.com › Dividends › Starbucks+(SBUXStarbucks (SBUX) Declares $0.57 Quarterly Dividend; 2.9% Yield

    1 hour ago · Starbucks (NASDAQ: SBUX) declared a quarterly dividend of $0.57 per share, or $2.28 annualized.The dividend will be payable on August 30, 2024, to stockholders of record on August 16, 2024, with an...

  5. uk.marketscreener.com › quote › stockTREMFYA® (guselkumab) studies underscore its potential to be ...

    21 hours ago · TREMFYA® Phase 3 Crohn's disease study achieves all primary and secondary endpoints SPRING HOUSE, Pa., June 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced positive topline results from...

  6. uk.marketscreener.com › quote › stockJohnson & Johnson submits application to U.S. FDA seeking ...

    21 hours ago · Submission is supported by 48-week results from the Phase 3 GALAXI and GRAVITI programs TREMFYA® is the only IL-23 inhibitor to demonstrate strong endoscopic outcomes with subcutaneous induction,...

  7. www.streetinsider.com › PRNewswire › Johnson+&ampJohnson & Johnson submits application to U.S. FDA seeking ...

    1 hour ago · Price: $147.78 +1.46% Overall Analyst Rating: SELL (= Flat) Dividend Yield: 3.3% EPS Growth %:-3.2% Join SI Premium – FREE Submission is supported by 48-week results from the Phase 3 GALAXI and ...

  8. www.morningstar.com › news › pr-newswireJohnson & Johnson submits application to U.S. FDA seeking ...

    21 hours ago · Media contact: Craig Stoltz +1 215-779-9396 Brian Kenney +1 215- 620-0111. Investor contact: Raychel Kruper investor-relations@its.jnj.com

  1. Ad

    related to: jnj dividend history
  2. JNJ.com

    Johnson & Johnson - J&J investor information

    Get information about J&J's stock, annual shareholder meeting, SEC filings and more. See how J&J is delivering long-term value for our stakeholders.

  1. Searches related to jnj dividend history

    jnj dividend history nasdaqpg dividend history
    jnj dividend history chartjnj dividend history increase
    aapl dividend historyjnj dividend history marketbeat
    dow dividend historypep dividend history
  2. People also search for